Nature Cancer

🚨 Our February Issue is out! Featuring: ☑️ Neoadjuvant PD‑1 in desmoplastic melanoma ☑️ FBXL2 inhibition sensitizes HER2‑neg breast cancer ☑️ Genomic model for prostate cancer screening ☑️ Organoid model for H3.3K27M glioma …and more! nature.com/natcancer/volu…

Now in Nature Cancer! @rashmikmurthy and colleagues provide evidence suggesting clinical benefit with the combination of tucatinib, capecitabine and trastuzumab as systemic regimen for women with HER2+ leptomeningeal metastasis nature.com/articles/s4301…

📢Come join our editorial team @NatureCancer We're hiring an Associate or Senior Editor! Apply to join our team in Shanghai, Beijing, Nanjing or Madrid. ⏲️Application deadline: March 29th Details: 👉springernature.wd3.myworkdayjobs.com/SpringerNature…

News and Views: ‘AI for breast cancer screening’ By Allan Hackshaw & Rosalind Given-Wilson Link: nature.com/articles/s4301…

📢Hot off the press @NatureCancer Don’t miss these 3 new Articles along with the accompanying News&Views on the use of AI in breast cancer screening!

‘Impact of using artificial intelligence as a second reader in breast screening including arbitration’ By Lucy Warren and colleagues Link: nature.com/articles/s4301…

‘Diagnostic accuracy, fairness and clinical implementation of AI for breast cancer screening: results of multicenter retrospective and prospective technical feasibility studies’ By Christopher Kelly and colleagues Link: nature.com/articles/s4301…

‘Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study’ By Clarisse de Vries and colleagues Link: nature.com/articles/s4301…

🌟New Resource article Read about the pancancer landscape of cancer-specific cell-free DNA methylation and fragmentomic features from plasma samples from 1,294 patients ✒️Yong Zeng, @MatLupien, @PughLab, Housheng Hansen He & colleagues nature.com/articles/s4301…

PERSPECTIVE hot off the press @NatureCancer ! 'Setting higher standards for reports of microbial species in human cancers' 🔗nature.com/articles/s4301… ✒️By Steven Salzberg, Jacques Neefjes & Niranjan Nagarajan and co-authors #tumormicrobiome

SpaceCat analyzes multiplex imaging data and establishes spatial patterns within triple-negative breast cancer microenvironment that are predictive of immune checkpoint blockade response across treatment time course. nature.com/articles/s4301…

QUICHE is a computational method that analyzes proteomic imaging and detects differentially enriched cellular niches, including low-prevalence niches. The tool informs antitumor responses in triple-negative breast cancer. nature.com/articles/s4301…

🌟Out today in Nature Cancer, two automated tools to analyze prognostic spatial features of TNBC @MikeAngeloLab @JoleneRanek @NoahGreenwald 🔗nature.com/articles/s4301… 🔗nature.com/articles/s4301… And read the associated News & Views from @hartjackson nature.com/articles/s4301…

⭐Technical Report out today at Nature Cancer The deep neural network M-PACT uses low-input cell-free DNA methylation profiles to classify pediatric brain tumors 🖊️By Paul A. Northcott & colleagues @StJudeResearch nature.com/articles/s4301…

Join us on Tuesday, Feb. 17 as Luca Danelli @NatureComms @NatureCancer presents, "Understanding the editorial process at Nature journals" at 12:30pm in Boyer 130. The seminar is open to all UCLA faculty, students and staff! 🐻

Meeting Report | Insights from ESMO Immuno-Oncology Congress 2025 nature.com/articles/s4301…

📢Don't miss this recently published @NatureCancer Article! 'METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers' ✒️By Housheng Hansen He, Xin Xu and colleagues 🔗nature.com/articles/s4301…

❄️Our January Issue is out! Featuring: ☑️immune atlas in multiple myeloma ☑️tumor microbiome in head & neck cancer ☑️MEK–RAF molecular glue against RAS/BRAF-mutant cancers ☑️atypical EMT ☑️CheckMate 77T phase 3 trial in patients with NSCLC and more! nature.com/natcancer/volu…

🌟New Perspective at Nature Cancer Tan and colleagues discuss recent advances in spatial omics and computational models that inform the classification and clinical relevance of cellular neighborhoods in cancer. 🔗nature.com/articles/s4301… @cdktmw

🌟New Perspective to read at Nature Cancer Learn about the current clinical and preclinical evidence of the effects of GLP-1 medicines on cancer outcomes and their mechanism in cancer cells and the TME. ✏️Julian M. Yabut & @DanielJDrucker nature.com/articles/s4301…